Edition:
India

Beigene Ltd (BGNE.OQ)

BGNE.OQ on NASDAQ Stock Exchange Global Select Market

132.22USD
15 Feb 2019
Change (% chg)

$-2.46 (-1.83%)
Prev Close
$134.68
Open
$134.95
Day's High
$135.57
Day's Low
$130.01
Volume
136,549
Avg. Vol
199,473
52-wk High
$220.09
52-wk Low
$105.19

Chart for

About

BeiGene, Ltd. is principally engaged in biopharmaceutical business. The Company is mainly engaged in the research and development, production and sales of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company's main products include Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317) and... (more)

Overall

Beta: --
Market Cap(Mil.): $4,400.80
Shares Outstanding(Mil.): 3.26
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates